Roles of GLUT-1 and HK-II Expression in the Biological Behavior of Head and Neck Cancer

Overview

Journal Oncotarget

Specialty Oncology

Date 2019 May 21

PMID 31105886

Citations 25

Authors

Hang Yang

Jiang-Tao Zhong

Shui-Hong Zhou

He-Ming Han

Affiliations

Soon will be listed here.

Abstract

The Warburg effect plays an important role in the proliferation and invasion of malignant tumors. Glucose transporter 1 and hexokinase II are two key energy transporters involved in mediating the Warburg effect. This review will analyze the mechanisms of these two markers in their effects on the biological behavior of head and neck cancer.

Citing Articles

Proliferation and migration inhibition of adenoid cystic carcinoma cells through autophagy suppression via GLUT1 knockdown.

Liu K, Zhu J, Bao Y, Fang J, Zhou S, Fan J Heliyon. 2025; 11(4):e42894.

PMID: 40070961 PMC: 11894374. DOI: 10.1016/j.heliyon.2025.e42894.

Momordicine-I suppresses head and neck cancer growth by modulating key metabolic pathways.

Bandyopadhyay D, Tran E, Patel R, Luetzen M, Cho K, Shriver L Cell Commun Signal. 2024; 22(1):597.

PMID: 39696286 PMC: 11657802. DOI: 10.1186/s12964-024-01951-w.

A Significant Increasing Risk Association between Cigarette Smoking and and Genes Polymorphisms.

Almushawwah S, Almutairi M, Alamri A, Semlali A Genes (Basel). 2023; 14(7).

PMID: 37510255 PMC: 10379612. DOI: 10.3390/genes14071349.

RNA-Based Liquid Biopsy in Head and Neck Cancer.

Kabzinski J, Kucharska-Lusina A, Majsterek I Cells. 2023; 12(14).

PMID: 37508579 PMC: 10377854. DOI: 10.3390/cells12141916.

Moonlight functions of glycolytic enzymes in cancer.

Shegay P, Shatova O, Zabolotneva A, Shestopalov A, Kaprin A Front Mol Biosci. 2023; 10:1076138.

PMID: 37449059 PMC: 10337784. DOI: 10.3389/fmolb.2023.1076138.

References

Younes M, Juarez D, Lechago L, Lerner S . Glut 1 expression in transitional cell carcinoma of the urinary bladder is associated with poor patient survival. Anticancer Res. 2001; 21(1B):575-8. View

Nakata B, Nishimura S, Ishikawa T, Ohira M, Nishino H, Kawabe J . Prognostic predictive value of 18F-fluorodeoxyglucose positron emission tomography for patients with pancreatic cancer. Int J Oncol. 2001; 19(1):53-8. DOI: 10.3892/ijo.19.1.53. View

Williams K, Telfer B, Airley R, Peters H, Sheridan M, van der Kogel A . A protective role for HIF-1 in response to redox manipulation and glucose deprivation: implications for tumorigenesis. Oncogene. 2002; 21(2):282-90. DOI: 10.1038/sj.onc.1205047. View

Higashi T, Saga T, Nakamoto Y, Ishimori T, Mamede M, Wada M . Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med. 2002; 43(2):173-80. View

Zimmerman R, Fogt F, Burke M, Murakata L . Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma. Oncol Rep. 2002; 9(4):689-92. View

Samih N, Hovsepian S, Notel F, Prorok M, Zattara-Cannoni H, Mathieu S . The impact of N- and O-glycosylation on the functions of Glut-1 transporter in human thyroid anaplastic cells. Biochim Biophys Acta. 2003; 1621(1):92-101. DOI: 10.1016/s0304-4165(03)00050-3. View

Tian M, Zhang H, Higuchi T, Oriuchi N, Nakasone Y, Takata K . Hexokinase-II expression in untreated oral squamous cell carcinoma: comparison with FDG PET imaging. Ann Nucl Med. 2005; 19(4):335-8. DOI: 10.1007/BF02984629. View

Robey R, Hay N . Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006; 25(34):4683-96. DOI: 10.1038/sj.onc.1209595. View

De Schutter H, Barbe B, Spaepen M, Begg A, Balm A, Gregoire V . Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1. Radiother Oncol. 2006; 80(2):143-50. DOI: 10.1016/j.radonc.2006.07.018. View

10.

Chandan V, Faquin W, Wilbur D, Khurana K . The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma. Cancer. 2006; 108(5):331-6. DOI: 10.1002/cncr.22172. View

11.

Mori Y, Tsukinoki K, Yasuda M, Miyazawa M, Kaneko A, Watanabe Y . Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors. Oral Oncol. 2006; 43(6):563-9. DOI: 10.1016/j.oraloncology.2006.06.006. View

12.

Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung Y . Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol. 2007; 61(3):377-93. DOI: 10.1007/s00280-007-0480-1. View

13.

Li S, Guo W, Ren G, Huang G, Chen T, Song S . Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg. 2007; 46(3):180-186. DOI: 10.1016/j.bjoms.2007.11.003. View

14.

Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K . Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci. 2008; 99(2):260-6. PMC: 11159204. DOI: 10.1111/j.1349-7006.2007.00683.x. View

15.

Nguyen X, So Y, Chung J, Lee W, Park S, Kim S . High correlations between primary tumours and loco-regional metastatic lymph nodes in non-small-cell lung cancer with respect to glucose transporter type 1-mediated 2-deoxy-2-F18-fluoro-D-glucose uptake. Eur J Cancer. 2008; 44(5):692-8. DOI: 10.1016/j.ejca.2008.02.009. View

16.

Zhou S, Wang S, Wu Q, Fan J, Wang Q . Expression of glucose transporter-1 and -3 in the head and neck carcinoma--the correlation of the expression with the biological behaviors. ORL J Otorhinolaryngol Relat Spec. 2008; 70(3):189-94. DOI: 10.1159/000124293. View

17.

Schrijvers M, van der Laan B, de Bock G, Pattje W, Mastik M, Menkema L . Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 72(1):161-9. DOI: 10.1016/j.ijrobp.2008.05.025. View

18.

Pedersen P . Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer. J Bioenerg Biomembr. 2008; 40(3):123-6. DOI: 10.1007/s10863-008-9165-7. View

19.

Mathupala S, Ko Y, Pedersen P . Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol. 2008; 19(1):17-24. PMC: 2714668. DOI: 10.1016/j.semcancer.2008.11.006. View

20.

Zhou S, Fan J, Chen X, Cheng K, Wang S . Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1. Head Neck. 2009; 31(12):1624-33. DOI: 10.1002/hed.21137. View